The World Health Organization (WHO) is seeking expressions of interest from individuals or entities with relevant expertise to perform a systematic review of the evidence for the diagnostic accuracy of targeted next-generation sequencing technologies for detection of drug resistance among people diagnosed with TB.
The deadline for applications is 13 May 2022.
For full details about the call, click here.